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تفسري تشخيص اخلالاي احلرشفية الالمنطية غري حمددة الداللة يف شرحية خالاي 
عنق الرحم وارتباطها بفريوس الورم احلليمي البشري
حتليل استعادي لـ 180 حالة يف الكويت
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abstract: Objectives: Atypical squamous cells of undetermined significance (ASC-US) represent a diagnostic 
challenge during cervical cytology. This study aimed to review and identify high-risk human papillomavirus 
(HR-HPV) genotypes among previously diagnosed ASC-US cases in Kuwait. Methods: This retrospective study 
analysed 180 cases diagnosed as ASC-US between June 2017 and May 2018 at the Mubarak Al-Kabeer Hospital, 
Kuwait. Cervical specimens were assayed to determine the presence of HR-HPV DNA; subsequently, positive cases 
underwent genotyping and were categorised into three groups (HPV 16, HPV 18/45 and other HR-HPV types). 
Results: In total, ASC-US was confirmed in only 105 cases (58.3%), with the remaining cases reclassified as negative 
for intraepithelial lesions or malignancy (NILM; 32.2%) and epithelial cell abnormalities (ECA; 9.4%). Of these, HR-
HPV DNA was present in 20 ASC-US (19%), one NILM (1.7%) and six ECA (35.3%) cases. There were 62 Kuwaiti 
and 43 non-Kuwaiti women with confirmed ASC-US; of these, three (4.8%), six (9.7%) and four (6.5%) Kuwaitis 
and one (2.3%), one (2.3%) and five (11.6%) non-Kuwaitis had HPV 16, both HPV 16 and 18/45 and other HR-
HPV genotypes, respectively. Of those with HR-HPV DNA, the NILM case had the HPV 18/45 genotype, while 
the six ECA cases had the HPV 16 (n = 1), both HPV 16 and 18/45 (n = 1) and other HR-HPV (n = 4) genotypes. 
Conclusion: Overall, HR-HPV DNA was present in 19% of ASC-US cases compared to 1.7% of NILM cases initially 
misdiagnosed as ASC-US. Re-review of cervical cytology diagnoses may reduce unnecessary costs associated with 
HR-HPV genotyping.
Keywords: Cervical Smears; Atypical Squamous Cells of Undetermined Significance; Human Papilloma Virus; Cytological 
Techniques; Papanicolaou Test; Kuwait.
امللخ�ص: الهدف: متثل اخلاليا احلر�شفية الالمنطية ذات الداللة غري املحددة )ASC-US( حتدًيا ت�شخي�شًيا اأثناء درا�شة م�شحات عنق الرحم. 
 ASC-US بني حاالت )HR-HPV( هدفت هذه الدرا�شة اإىل مراجعة وحتديد االأمناط اجلينية عالية اخلطورة لفريو�س الورم احلليمي الب�رصي
التي مت ت�شخي�شها �شابًقا يف الكويت. الطريقة: حللت هذه الدرا�شة باأثر رجعي 180 حالة مت ت�شخي�شها على اأنها ASC-US بني يونيو 2017 
ومايو 2018 يف م�شت�شفى مبارك الكبري، الكويت. مت فح�س عينات عنق الرحم لتحديد وجود ال�شيفرة الوراثية )DNA( لفريو�س الورم احلليمي 
الب�رصي. بعد ذلك، مت ت�شنيف احلاالت االإيجابية جينيا اإىل ثالث جمموعات )HPV 16 و HPV 18/45 واأنواع اأخرى من HR-HPV(. النتائج: 
يف املجموع، مت تاأكيد ASC-US يف 105 حالة فقط )%58.3(، مع اإعادة ت�شنيف احلاالت املتبقية على اأنها �شلبية لالآفات داخل الظهارة اأو 
-US 20 موجوًدا يف DNA HR-HPV ؛ %9.4(. من بني تلك، كانECA( ؛ %32.2( وت�شوهات اخلاليا الظهاريةNILM( االأورام اخلبيثة
ASC )%19( ، وحالة NILM واحدة )%1.7( و�شت حاالت ECA )%35.3(. كانت هناك 62 امراأة كويتية و 43 امراأة غري كويتية لديهن حاالت 
موؤكدة من ASC-US؛ من هوؤالء، ثالثة )%4.8( و�شتة )%9.7( واأربعة )%6.5( كويتيون وواحد )%2.3( وواحد )%2.3( وخم�شة )%11.6( من غري 
الكويتيني لديهم فريو�س الورم احلليمي الب�رصي 16، وكل من HPV 16 و 18/45 واالأمناط اجلينية االأخرى HR-HPV، على التوايل. من بني 
الذين لديهم DNA HR-HPV، كانت حالة NILM حتتوي على النمط الوراثي HPV 18/45، يف حني اأن حاالت ECA ال�شت كانت حتتوي 
على واحد من HPV 16 وواحد من HPV 16 و 18/45 واأربعة من-HR فريو�س الورم احلليمي الب�رصي من االأمناط اجلينية. اخلال�صة: ب�شكل 
عام، كان HR-HPV DNA موجوًدا يف %19من حاالت ASC-US مقارنة بـ %1.7 من حاالت NILM التي مت ت�شخي�شها ب�شكل خاطئ يف 
البداية على اأنها ASC-US. قد توؤدي اإعادة مراجعة ت�شخي�س اخلاليا العنقية اإىل تقليل التكاليف غري ال�رصورية املرتبطة بالتنميط اجليني 
.HR-HPV
الب�رصي؛ تقنيات  الورم احلليمي  الداللة غري املحددة؛ فريو�س  الرحم؛ اخلاليا احلر�شفية الالمنطية ذات  املفتاحية: م�شحات عنق  الكلمات 
اخلاليا؛ اختبار بابانيكوالو الكويت.
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Advances in Knowledge 
- This study identified the prevalence of high-risk human papillomavirus (HR-HPV) genotypes in cervical smears previously diagnosed 
as atypical squamous cells of undetermined significance (ASC-US) in Kuwait. Despite the relatively high incidence of epithelial cell 
abnormalities, few studies on this topic have been conducted in the Gulf Cooperative Council region.
- The current study found that only 58.3% of previously diagnosed cases of ASC-US were confirmed retrospectively. Moreover, HR-HPV 
genotypes were found in 19% of confirmed ASC-US cases compared to only 1.7% of normal cases initially misdiagnosed as ASC-US. 
Application to Patient Care
- The findings of this study indicate that the re-review of ASC-US cases is important, not only to avoid potential misdiagnosis and causing 
unnecessary emotional distress for the patient, but also to determine which cases warrant further HR-HPV typing, a needless expense in 
low-risk cases.
The presence of atypical squamous cells on cervical smears represents a diagnostic challenge for both pathologists and 
clinicians.1 According to the revised Bethesda 
classification system, cervical epithelial abnormalities 
are categorised as either atypical squamous cells 
of undetermined significance (ASC-US), atypical 
squamous cells without ruling out a high-grade 
lesion (ASC-H), low-grade squamous intraepithelial 
lesions (LSIL), high-grade squamous intraepithelial 
lesions (HSIL) or squamous cell carcinomas.2 Under 
this system, a diagnosis of ASC-US is issued when 
the cervical epithelial cells demonstrate cytological 
changes suggestive of a squamous intraepithelial 
lesion, but without definitive qualitative or quantitative 
confirmation.3 Despite the existence of these 
diagnostic criteria, accurate identification of ASC-US 
cases remains difficult, thus resulting in high rates of 
misdiagnosis and overinterpretation during cervical 
cytology screening.1,3 
In humans, the vast majority of cases of 
cervical cancer are linked to human papillomavirus 
(HPV) infections.4 As such, HPV testing is highly 
recommended for patients diagnosed with ASC-US 
in order to determine whether further follow-up, 
in the form of an urgent colposcopy, is necessary.5 
There are over 100 different HPV genotypes, of which 
approximately 40 are known to infect the genital tract; 
of these, 18 are believed to play a significant role in 
the pathogenesis of cervical cancers, most commonly 
types 16, 18 and 45.6 These variants are therefore 
considered to represent high-risk HPV (HR-HPV) 
genotypes.4,6
Few studies have sought to assess the spectrum 
of HR-HPV genotypes among women in Gulf 
Cooperation Council (GCC) countries, which differ 
significantly from those reported elsewhere in the 
world likely as a result of racial diversity.7–11 For 
instance, previous research indicates that HR-HPV 
genotypes in Kuwait mostly consist of types other than 
16, 18 and 45.8 Similarly, Ali et al. showed that HR-
HPV types other than 16 and 18 were most prevalent 
in GCC countries.7 This study aimed to review 
previously diagnosed ASC-US cases at a hospital in 
Kuwait to determine the rate of overinterpretation as 
well as to identify the prevalence of specific HR-HPV 
genotypes among Kuwaiti and non-Kuwaiti women.
Methods 
This retrospective study reviewed 180 cases diagnosed 
as ASC-US between June 2017 and May 2018 at the 
Mubarak Al-Kabeer Hospital, Kuwait. Cytological 
data from ThinPrep® cervical smears (Hologic Corp., 
Bedford, Massachusetts, USA) were retrieved from the 
files of the cytology laboratory. Each case underwent 
blinded peer-review by two pathologists and one 
senior cytotechnician to confirm or correct the initial 
ASC-US diagnosis. Cases were classified using the 
2014 revised Bethesda system as either negative for 
intraepithelial lesions or malignancy (NILM), ASC-
US, atypical glandular cells (AGC), LSILs or HSILs.2 
Subsequently, the cervical samples were assayed 
to determine the presence of HR-HPV DNA. The 
assay technique was conducted using the Panther 
system of the Aptima™ HPV Assay (Hologic Corp.). 
Samples from the ThinPrep® vials were transferred to 
the Aptima™  transfer tube in order to capture, amplify, 
detect and report specific HR-HPV E6/E7 messenger 
ribonucleic acid transcripts. Cases were then 
categorised as either HR-HPV-positive (relative light 
unit/cut-off [RLU/CO] of ≥0.5) or HR-HPV-negative 
(RLU/CO of <0.5). Subsequently, the Aptima™  HPV 
16 18/45 Genotype Assay (Hologic Corp.) was used to 
detect HR-HPV 16 and 18/45 genotypes in HR-HPV-
positive cases.
Based on the results of the assay, HR-HPV-
positive cases were subdivided into the following 
categories: (1) positive for HPV 16; (2) positive for 
HPV 18/45; (3) positive for both HPV 16 and 18/45; 
or (4) negative for both HPV 16 and 18/45. For the 
latter category, the absence of both HPV 16 and 18/45 
genotypes was considered to imply the presence 
of other HR-HPV genotypes, given the HR-HPV-
positive findings observed during the initial assay. For 
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the purposes of statistical analysis, the results of HR-
HPV testing were correlated with both the corrected 
cytological diagnosis (i.e. NILM, ASC-US, AGC, LSIL 
or HSIL) and nationality (i.e. Kuwaiti or non-Kuwaiti).
This study was conducted in accordance with 
the Combined Ethics Committee of the Kuwaiti 
Ministry of Health and the Faculty of Medicine of 
the Health Science Centre, University of Kuwait. The 
procedures of the study conformed to the ethical 
guidelines outlined in the revised Declaration of 
Helsinki. Informed verbal consent was obtained from 
all patients.
Results
Of the 180 previously diagnosed ASC-US cases, the 
original diagnosis was confirmed retrospectively by 
peer-review in only 105 cases (58.3%). The remaining 
cases were reclassified as either NILM (n = 58; 32.2%) 
or epithelial cell abnormalities (ECA; n = 17; 9.4%), 
with the latter comprising seven AGC (3.9%), six 
LSIL (3.3%), two HSIL (1.1%) and two ASC-US with 
AGC (1.1%). Among the 58 NILM cases, only one 
(1.7%) was HR-HPV-positive; in contrast, HR-HPV 
DNA was present in 20 ASC-US (19%) and six ECA 
(35.3%) cases. Overall, the HPV 16, HPV 18/45 and 
both HPV 16 and 18/45 genotypes were present in five 
(2.8%), one (0.6%) and eight (4.4%) cases, respectively. 
The remaining 13 cases (7.2%) were negative for both 
HPV 16 and 18/45, indicating the presence of HR-
HPV variants other than types 16 and 18/45 in these 
specimens. Only one of the NILM cases (1.7%) and two 
of the ECA cases (11.8%) demonstrated the common 
HR-HPV genotypes 16 or 18/45 [Table 1].
Table 1: Reclassification of and prevalence of human papillomavirus genotypes among cervical cytology cases previously 
diagnosed as atypical squamous cells of undetermined significance (N = 180)
Reclassification HPV status, n (%)
Total Negative Type 16 Type 18/45 Types 16 
and 18/45
Other Unknown*
NILM 58 (32.2) 56 (96.6) 0 (0) 1 (1.7) 0 (0) 0 (0) 1 (1.7)
ASC-US 105 (58.3) 84 (80) 4 (3.8) 0 (0) 7 (6.7) 9 (8.6) 1 (1)
AGC 7 (3.9) 7 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
ASC-US and 
AGC
2 (1.1) 2 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
LSIL 6 (3.3) 2 (33.3) 1 (16.7) 0 (0) 1 (16.7) 2 (33.3) 0 (0)
HSIL 2 (1.1) 0 (0) 0 (0) 0 (0) 0 (0) 2 (100) 0 (0)
Total 180 (100) 151 (83.9) 5 (2.8) 1 (0.6) 8 (4.4) 13 (7.2) 2 (1.1)
HPV = human papillomavirus; NILM = negative for intraepithelial lesions or malignancy; ASC-US = atypical squamous cells of undetermined signif- 
icance; AGC = atypical glandular cells; LSIL = low-grade squamous intraepithelial lesions; HSIL = high-grade squamous intraepithelial lesions. 
*Testing not performed.
Table 2: Reclassification of and prevalence of human papillomavirus genotypes among cervical cytology cases previously 
diagnosed as atypical squamous cells of undetermined significance in the Kuwaiti group (N = 104)
Reclassification HPV status, n (%)
Total Negative Type 16 Type 18/45 Types 16 
and 18/45
Other Unknown*
NILM 36 (34.6) 34 (94.4) 0 (0) 1 (2.8) 0 (0) 0 (0) 1 (2.8)
ASC-US 62 (59.6) 49 (79) 3 (4.8) 0 (0) 6 (9.7) 4 (6.5) 0 (0)
AGC 2 (1.9) 2 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
ASC-US and 
AGC
2 (1.9) 2 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
LSIL 2 (1.9) 0 (0) 1 (50) 0 (0) 0 (0) 1 (50) 0 (0)
HSIL 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Total 104 (100) 87 (83.7) 4 (3.8) 1 (1) 6 (5.8) 5 (4.8) 1 (1)
HPV = human papillomavirus; NILM = negative for intraepithelial lesions or malignancy; ASC-US = atypical squamous cells of undetermined signif- 
icance; AGC = atypical glandular cells; LSIL = low-grade squamous intraepithelial lesions; HSIL = high-grade squamous intraepithelial lesions. 
*Testing not performed.
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In terms of nationality, the specimens originated 
from 104 Kuwaiti women and 76 women of other 
nationalities. In the Kuwaiti group, 16 cases (15.4%) 
were HR-HPV-positive; of these, the HPV 16 genotype 
was present in four (25%) cases, HPV 18/45 in one 
(6.3%) and both HPV 16 and 18/45 in six (37.5%). 
However, five cases (31.3%) were negative for both 
HPV 16 and 18/45, indicating the presence of other 
HR-HPV variants [Table 2]. In the non-Kuwaiti 
group, 11 cases (14.5%) were HR-HPV positive. These 
included one case (9.1%) with the HPV 16 genotype 
and two (18.2%) with both HPV 16 and 18/45. Other 
HR-HPV genotypes were assumed in the remaining 
eight cases (72.7%) [Table 3].
The diagnosis of ASC-US was confirmed in 62 
Kuwaiti and 43 non-Kuwaiti cases. Of these, HR-HPV 
DNA was present in 13 (21%) and seven (16.3%) cases, 
respectively. In the Kuwaiti ASC-US group, genotyping 
for the HPV 16, both HPV 16 and 18/45 and other 
HR-HPV variants was positive in three (4.8%), six 
(9.7%) and four (6.5%) cases, respectively. In contrast, 
genotyping for these types was positive in one (2.3%), 
one (2.3%) and five (11.6%) cases, respectively, in the 
non-Kuwaiti ASC-US group [Table 4]. 
Discussion
The diagnosis of ASC-US depends not only on the 
identification of well-defined cytological patterns, but 
also on other more subjective criteria; consequently, 
reproducibility of the diagnosis upon re-review 
can vary from <50–67.9%.1,12 Various studies have 
shown that a number of factors are related to 
the overinterpretation of atypical squamous cells 
including reactive changes due to reproductive tract 
infections associated with Trichomonas vaginalis, 
Candida species and bacterial vaginosis, as well as the 
presence of intermediate squamous cells with bland 
nuclear enlargement without chromatin and nuclear 
abnormalities.5,13 Moreover, ASC-US diagnoses are 
reported more frequently in women who are pregnant, 
lactating and postmenopausal due to the excessive 
glycogenation of intermediate squamous cells caused 
by hormones.5,13 In addition, the presence of immature 
metaplastic cells, suboptimal fixation, drying artifacts 
and other age-related changes such as degeneration 
due to atrophic vaginitis may be mistaken for ASC-
US.5,13,14
Table 3: Reclassification of and prevalence of human papillomavirus genotypes among cervical cytology cases previously 
diagnosed as atypical squamous cells of undetermined significance in the non-Kuwaiti group (N = 76)
Reclassification HPV status, n (%)
Total Negative Type 16 Type 18/45 Types 16 
and 18/45
Other Unknown*
NILM 22 (28.9) 22 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
ASC-US 43 (56.6) 35 (81.4) 1 (2.3) 0 (0) 1 (2.3) 5 (11.6) 1 (2.3)
AGC 5 (6.6) 5 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
ASC-US and 
AGC
0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
LSIL 4 (5.3) 2 (50) 0 (0) 0 (0) 1 (25) 1 (25) 0 (0)
HSIL 2 (2.6) 0 (0) 0 (0) 0 (0) 0 (0) 2 (100) 0 (0)
Total 76 (100) 64 (84.2) 1 (1.3) 0 (0) 2 (2.6) 8 (10.5) 1 (1.3)
HPV = human papillomavirus; NILM = negative for intraepithelial lesions or malignancy; ASC-US = atypical squamous cells of undetermined signif- 
icance; AGC = atypical glandular cells; LSIL = low-grade squamous intraepithelial lesions; HSIL = high-grade squamous intraepithelial lesions. 
*Testing not performed.
Table 4: Distribution of human papillomavirus genotypes according to nationality among cases with confirmed diagnoses 
of atypical squamous cells of undetermined significance (N = 105)
Nationality HPV status, n (%)
Total Negative Type 16 Type 18/45 Types 16 
and 18/45
Other Unknown*
Kuwaiti 62 (59) 49 (79) 3 (4.8) 0 (0) 6 (9.7) 4 (6.5) 0 (0)
Non-Kuwaiti 43 (41) 35 (81.4) 1 (2.3) 0 (0) 1 (2.3) 5 (11.6) 1 (2.3)
Total 105 (100) 84 (80) 4 (3.8) 0 (0) 7 (6.7) 9 (8.6) 1 (1)
HPV = human papillomavirus. *Testing not performed.
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In the current study, all cases previously 
diagnosed as ASC-US at a Kuwaiti hospital over a 
one-year period were reviewed retrospectively by 
three cytologists. Overall, only 58.3% of cases received 
confirmation of the ASC-US diagnosis, while the 
remaining cases were reclassified as either NILM 
(32.2%) or ECA (9.4%). This rate of reproducibility was 
comparable to that reported in previous research.1,12 
The absence of well-defined cytological criteria, 
subjectivity of the diagnosis and various other factors 
may account for the overrepresentation of ASC-US 
diagnoses in routine reporting.5,13,14 In general, accurate 
identification of ASC-US remains a diagnostic dilemna 
for cytopathologists. Consequently, HPV genotyping 
is often incorporated to enhance cervical screening. 
However, this can represent a needless expense due to 
the high rate of false-positive diagnoses. The authors 
therefore recommend that ASC-US diagnoses be 
peer-reviewed prior to reporting in order to decrease 
costs associated with unnecessary HPV genotyping.
In general, the detection of HR-HPV genotypes 
is a useful tool to supplement abnormal cytological 
results. Among patients with ASC-US, the presence of 
an HR-HPV-positive genotype increases the likelihood 
of cervical intraepithelial neoplasia (CIN) grades II 
or III, a precursor to cervical cancer; in contrast, a 
negative HR-HPV test excludes high-grade CIN.1 As 
a result, HR-HPV genotyping is usually recommended 
for patients with ASC-US.15 However, the American 
Society for Colposcopy and Cervical Pathology does 
not recommend HPV testing be performed for women 
aged 21–29 years, instead encouraging such individuals 
to undergo cytological screening only every three 
years.16 For women aged 30–65 years, both cytological 
screening and HPV testing is recommended every 
five years; alternatively, screening with cytology alone 
can be performed every three years. In addition, HPV 
testing is recommended for women with LSIL and as 
a post-colposcopy follow-up measure for those with 
abnormal cytology.16–18 Cases found to be positive for 
HR-HPV should undergo a colposcopic examination, 
while those classified as NILM should return for 
repeated cervical cytology screening within six 
months.
In the current study, the most common HR-
HPV types among HR-HPV-positive patients with 
confirmed ASC-US were HPV types other than 16 
and 18/45 (45%). Few studies have been performed to 
determine the most prevalent HR-HPV genotypes in 
the GCC region.7–11 Ali et al. found that types other 
than HPV 16/18 were the most common genotypes 
among women residing in Saudi Arabia, Qatar, the 
United Arab Emirates and Bahrain, followed by type 
HPV 16.7 Similarly, Mallik et al. reported that the most 
prevalent HR-HPV genotypes in Kuwait were those 
other than types 16, 18 and 45.8 However, Al-Awadhi 
et al. reported contradictory findings indicating that 
HPV type 16 was most frequent in a cohort of women 
in Kuwait.11 In the present study, the most common 
HR-HPV genotypes among HR-HPV-positive Kuwaiti 
women regardless of cytological diagnosis were both 
HPV 16 and 18/45 (37.5%), followed by HR-HPV types 
other than 16 and 18/45 (31.3%), HPV 16 (25%) and 
HPV 18/45 (6.3%). Among HR-HPV-positive non-
Kuwaiti women, the most prevalent genotypes were 
HR-HPV types other than 16 and 18/45 (72.7%), both 
HPV 16 and 18/45 (18.2%) and HPV 16 (9.1%).
Conclusion
The rate of overrepresentation of ASC-US cases at a 
Kuwaiti hospital over a one-year period was moderately 
high. In addition, HR-HPV DNA was present in 19% 
of confirmed ASC-US cases compared to only 1.7% 
of NILM cases initially misdiagnosed as ASC-US. 
Therefore, the authors strongly recommend that 
cytological diagnoses of ASC-US be peer-reviewed 
for diagnostic confirmation before undergoing HR-
HPV genotyping. Careful review of cellular changes 
by multiple cytologists will increase the diagnostic 
accuracy of cytology screening, thereby reducing the 
patient’s anxiety as well as the cost of unnecessary 
HPV genotyping for false-positive cases. 
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